Salarius Pharmaceuticals Inc’s recently made public that its Director HANISH ARNOLD C acquired Company’s shares for reported $3740.0 on Nov 20 ’25. In the deal valued at $0.75 per share,5,000 shares were bought. As a result of this transaction, HANISH ARNOLD C now holds 5,015 shares worth roughly $3911.7000000000003.
Then, Rosenblum Mark J bought 20,000 shares, generating $16,000 in total proceeds. Upon buying the shares at $0.80, the Exec VP Finance, CFO now owns 20,177 shares.
Ladenburg Thalmann initiated its Salarius Pharmaceuticals Inc [SLRX] rating to a Buy in a research note published on April 27, 2020; the price target was $3.80.
Price Performance Review of SLRX
On Monday, Salarius Pharmaceuticals Inc [NASDAQ:SLRX] saw its stock unchanged to $0.78. Over the last five days, the stock has lost -6.02%. Salarius Pharmaceuticals Inc shares have fallen nearly -96.71% since the year began. Nevertheless, the stocks have fallen -97.17% over the past one year. While a 52-week high of $108.00 was reached on 01/13/25, a 52-week low of $0.71 was recorded on 11/19/25.
Levels Of Support And Resistance For SLRX Stock
The 24-hour chart illustrates a support level at 0.7333, which if violated will result in even more drops to 0.6867. On the upside, there is a resistance level at 0.8633. A further resistance level may holdings at 0.9467.
How much short interest is there in Salarius Pharmaceuticals Inc?
A steep rise in short interest was recorded in Salarius Pharmaceuticals Inc stocks on 2025-11-28, dropping by -0.18 million shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 0.36 million shares. There was a decline of -95.47%, which implies that there is a negative sentiment for the stock.
